透析方式与出院后再入院:一项基于人群的队列研究
该研究纳入加拿大安大略省164家急性护理医院2003年1月1日至2013年12月31日期间维持性透析患者出院后情况,采用倾向性评分将每例腹膜透析患者匹配2例中心血液透析患者。匹配队列中腹膜透析患者30天再入院风险高于中心血液透析患者(调整后HR 1.19;95%CI 1.08-1.31)。
要点
- 匹配队列中腹膜透析患者30天再入院率为7.1/1000人日(95%CI 6.6-7.6),中心血液透析患者为6.0/1000人日(95%CI 5.7-6.3)。
- 腹膜透析患者30天再入院风险高于中心血液透析患者(调整后HR 1.19;95%CI 1.08-1.31)。
- 作者认为需要改善住院与门诊之间的护理过渡,尤其是腹膜透析患者。
核心结论
- 居家腹膜透析患者30天再入院风险高于中心血液透析患者。
- 作者认为需要改善住院与门诊之间的护理过渡,尤其是腹膜透析患者。
研究设计与样本
- 基于人群的回顾性队列观察性研究。
- 纳入2003年1月1日至2013年12月31日期间在加拿大安大略省164家急性护理医院急性住院后出院的维持性透析患者。
- 对多次住院者随机选取一次住院作为索引住院。
- 共纳入28,026例透析患者,其中4,013例腹膜透析患者与8,026例中心血液透析患者匹配。
- 采用倾向性评分将每例腹膜透析患者匹配2例中心血液透析患者。
主要发现
- 匹配队列中腹膜透析患者30天再入院率为7.1/1000人日(95%CI 6.6-7.6)。
- 匹配队列中中心血液透析患者30天再入院率为6.0/1000人日(95%CI 5.7-6.3)。
- 腹膜透析患者30天再入院风险高于中心血液透析患者(调整后HR 1.19;95%CI 1.08-1.31)。
- 主要结果在几个预设关键亚组中一致。
临床怎么用
- 作者认为需要改善住院与门诊之间的护理过渡,尤其是腹膜透析患者。
局限性
- 缺乏腹膜透析和中心血液透析两个队列出院后肾脏科医生就诊频率的信息。
- 国际疾病分类第十版编码的验证有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Readmissions following hospital discharge among maintenance dialysis patients are common, potentially modifiable, and costly. Compared with patients receiving in-center hemodialysis (HD), patients receiving peritoneal dialysis (PD) have fewer routine dialysis clinic encounters and as a result may be more susceptible to a hospital readmission following discharge. STUDY DESIGN: Population-based retrospective-cohort observational study. SETTINGS & PARTICIPANTS: Patients treated with maintenance dialysis who were discharged following an acute-care hospitalization during January 1, 2003, to December 31, 2013, across 164 acute-care hospitals in Ontario, Canada. For those with multiple hospitalizations, we randomly selected a single hospitalization as the index hospitalization. PREDICTOR: Dialysis modality PD or in-center HD. Propensity scores were used to match each patient on PD therapy to 2 patients on in-center HD therapy to ensure that baseline indicators of health were similar between the 2 groups. OUTCOME: All-cause 30-day readmission following the index hospital discharge. RESULTS: 28,026 dialysis patients were included in the study. 4,013 PD patients were matched to 8,026 in-center HD patients. Among the matched cohort, 30-day readmission rates were 7.1 (95% CI, 6.6-7.6) per 1,000 person-days for patients on PD therapy and 6.0 (95% CI, 5.7-6.3) per 1,000 person-days for patients on in-center HD therapy. The risk for a 30-day readmission among patients on PD therapy was higher compared with those on in-center HD therapy (adjusted HR, 1.19; 95% CI, 1.08-1.31). The primary results were consistent across several key prespecified subgroups. LIMITATIONS: Lack of information for the frequency of nephrology physician encounters following discharge from the hospital in both the PD and in-center HD cohorts. Limited validation of International Classification of Diseases, Tenth Revision codes. CONCLUSIONS: The risk for 30-day readmission is higher for patients on home-based PD compared to in-center HD therapy. Interventions to improve transitions in care between the inpatient and outpatient settings are needed, particularly for patients on PD therapy.
引用
- Perl J, McArthur E, Bell C, et al. Dialysis Modality and Readmission Following Hospital Discharge: A Population-Based Cohort Study. Am J Kidney Dis. 2017. PMID: 28069285. doi:10.1053/j.ajkd.2016.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。